Exicure, Inc. Common Stock XCUR

$1.04 -3.70% at last close
Market Cap$7.07 million
P/E Ratio—
Div Yield—
Volume4.5K
52-Week Range $0.78$9.48

Key Stats

Today's Range
$1.01 – $1.08
50-Day Range
$0.78 – $1.43
52-Week Range
$0.78 – $9.48
Volume
4K shs
Average Volume
83K shs
Market Cap
$7.07 million
P/E Ratio
—
Dividend Yield
—

Short Interest

Short Interest
0.01%
Days to Cover
1.00

About Exicure, Inc. Common Stock

Exicure Inc is a clinical-stage biotechnology company focused on developing treatments for blood-related diseases, with an emphasis on small-molecule therapies that have the potential to benefit a broad range of patients. The company acquired GPCR Therapeutics USA and secured a license for GPC-100 (Burixafor), a clinical-stage small-molecule compound that inhibits the chemokine receptor CXCR4. GPC-100 has demonstrated the ability to effectively mobilize various cell types, including hematopoietic stem cells and lymphocytes, highlighting its broad therapeutic potential across multiple indications.

Sector
PHARMACEUTICAL PREPARATIONS
Employees
8
Exchange
XNAS
Listed
2018-05-09

Related Stocks

Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.